80 per cent COVID-19 immunity lost in 6 months in some after Pfizer shot: US study
3 years, 3 months ago

80 per cent COVID-19 immunity lost in 6 months in some after Pfizer shot: US study

Deccan Chronicle  

Washington: COVID-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found. The research led by Case Western Reserve University and Brown University in the US studied blood samples of 120 nursing home residents and 92 health care workers. By six months after vaccination, the blood of 70 per cent of these nursing home residents had "very poor ability to neutralise the coronavirus infection in laboratory experiments," said David Canaday, a professor at the Case Western Reserve University. Early in the pandemic, higher COVID-19 mortality among nursing home residents in the US led to making them a priority for vaccination, the researchers said.

Nursing Residents Six Months Pfizer  covid19  immunity  months  â  lost  80  study  pfizer  residents  nursing  vaccine  shot  cent  caregivers  western

History of this topic

California’s COVID surge is finally over. But expect another spike in the coming months
2 months, 3 weeks ago

California’s COVID surge is finally over. But expect another spike in the coming months

LA Times  

California’s protracted summer COVID surge has finally ended, a welcome window that provides a key opportunity to prepare for yet another expected resurgence of transmission this autumn and winter, doctors say. “We have an updated COVID vaccine, an updated flu vaccine, an RSV vaccine — all of those can help protect ourselves, our families, our communities.” California New COVID subvariant …

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive
5 months ago

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive

Live Mint  

New Delhi: With US President Joe Biden testing positive for COVID-19 before the Presidential elections, the World Health Organisation has warned the public that Covid is still not over. WHO director-general Tedros Adhanom Ghebreyesus issued a warning, stating that vaccination rates among health professionals and the over-60s—two demographics most at risk of dying from COVID—are alarmingly falling. Globally, 9.8 million …

Here are the numbers: COVID-19 is ticking up in some places, but levels remain low
5 months, 3 weeks ago

Here are the numbers: COVID-19 is ticking up in some places, but levels remain low

Associated Press  

Here’s a look at the state of COVID-19 in the U.S. as the Centers for Disease Control and Prevention establishes its latest advice on vaccinations. Nearly 26,000 people died from COVID-19 in the U.S. in the week ending Jan. 9, 2021 — the highest weekly toll in the pandemic. Cases Individual COVID-19 cases are no longer tracked, but health officials …

As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign
5 months, 3 weeks ago

As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign

Associated Press  

NEW YORK — With fresh COVID-19 cases bubbling up in some parts of the country, health officials are setting course for a fall vaccination campaign. What’s more, health officials have reported upticks this month in COVID-19-associated emergency room visits and hospitalizations, and a pronounced increase in positive test results in the southwestern U.S. It’s not clear whether that’s a sign …

As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign
5 months, 3 weeks ago

As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

A German man who received 217 COVID vaccinations becomes focus of new immunisation research
9 months, 2 weeks ago

A German man who received 217 COVID vaccinations becomes focus of new immunisation research

ABC  

In short: German researchers have studied the immune response of a 62-year-old man who they say had received more than 200 COVID shots for "private reasons" within the space of 29 months. German researchers have studied the immune response of a 62-year-old man who they say had received more than 200 COVID shots for "private reasons" within the space of …

Newest COVID shots are 54% effective in preventing symptoms, CDC finds
10 months, 3 weeks ago

Newest COVID shots are 54% effective in preventing symptoms, CDC finds

Associated Press  

NEW YORK — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work. The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of …

COVID-19 makes a wintertime comeback
1 year ago

COVID-19 makes a wintertime comeback

Hindustan Times  

Germany is sniffling and coughing again. "We no longer see severe cases," he said, adding just one patient, aged 94, had to go to the hospital due to COVID-19. With as much as 10% of the country sick, according to Germany's Robert Koch Institute for public health, offices and services are struggling to stay open. Other forms of PCR testing …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Learning from Covid-19 vaccination experience
1 year ago

Learning from Covid-19 vaccination experience

Hindustan Times  

A recent scientific article titled “Factors associated with sudden deaths among adults aged 18-45 years in India”, based on a multicentric matched case-control study led by the Indian Council of Medical Research scientists and published in the Indian Journal of Medical Research, has triggered a lot of interest. The study did not find evidence to link the risk of unexplained …

Covid-19 vaccination rate is ‘lower than we’d like to see,’ CDC says
1 year, 1 month ago

Covid-19 vaccination rate is ‘lower than we’d like to see,’ CDC says

CNN  

CNN — Respiratory virus season is ramping up across the United States, and the US Centers for Disease Control and Prevention is warning that low vaccination rates are leaving many at risk. There are a number of reasons why it’s important for people to get the latest Covid-19 vaccine, CDC Director Dr. Mandy Cohen told CNN. “COVID-19 vaccines don’t prevent …

2% of kids and 7% of adults have gotten the new COVID shots, US data show
1 year, 1 month ago

2% of kids and 7% of adults have gotten the new COVID shots, US data show

Associated Press  

NEW YORK — A month after federal officials recommended new versions of COVID-19 vaccines, 7% of U.S. adults and 2% of children have gotten a shot. One expert called the rates “abysmal.” The numbers, presented Thursday at a meeting held by the Centers for Disease Control and Prevention, come from a national survey of thousands of Americans, conducted two weeks …

More COVID shots are coming. Will a weary public be more interested this year?
1 year, 3 months ago

More COVID shots are coming. Will a weary public be more interested this year?

LA Times  

A new coronavirus shot will be available starting this week, but the big question is how many people will get one. In a Kaiser Family Foundation poll published in April, 32% of adult respondents said they were “very” likely to get a COVID-19 vaccine offered annually, like the flu shot; while another 21% said they were “somewhat” likely. Among adults, …

New COVID-19 vaccinations are coming, CDC says. The shots will likely be available this week
1 year, 3 months ago

New COVID-19 vaccinations are coming, CDC says. The shots will likely be available this week

LA Times  

Allan Fernandez, 7, middle, is vaccinated by Dr. David Bolour, left, as CDC Director Dr. Rochelle Walensky looks on in Ted Watkins Memorial Park last year. “Although hospitalization rates are currently low in some age groups, we have seen rates increase in recent weeks, and anticipate further increases as we enter respiratory virus season.” CDC Director Dr. Mandy Cohen on …

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 3 months ago

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots

India Today  

The U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

Updated COVID shots are coming. They’re part of a trio of vaccines to block fall viruses
1 year, 3 months ago

Updated COVID shots are coming. They’re part of a trio of vaccines to block fall viruses

Associated Press  

WASHINGTON — Updated COVID-19 vaccines are coming soon, just in time to pair them with flu shots. Doctors hope enough people get vaccinated to help avert another “tripledemic” like last year when hospitals were overwhelmed with an early flu season, an onslaught of RSV, or respiratory syncytial virus, and yet another winter coronavirus surge. Similar to how flu shots are …

High Levels of Exposure to Covid Virus May Reduce Protection from Vaccination, Prior Infection: Study
1 year, 4 months ago

High Levels of Exposure to Covid Virus May Reduce Protection from Vaccination, Prior Infection: Study

News 18  

High levels of exposure to the SARS-CoV-2 virus may reduce or overcome the protection that COVID-19 vaccination and prior infection provides, according to a study conducted in the US. Hybrid immunity provided the highest level of protection, at 95 per cent and 71 per cent effectiveness, in residents without a documented exposure and with a cell exposure, respectively, according to …

High levels of exposure to Covid virus may reduce protection from vaccination, prior infection: Study
1 year, 4 months ago

High levels of exposure to Covid virus may reduce protection from vaccination, prior infection: Study

Hindustan Times  

High levels of exposure to the SARS-CoV-2 virus may reduce or overcome the protection that COVID-19 vaccination and prior infection provides, according to a study conducted in the US. Specifically, during the Delta wave, vaccination was 68 per cent effective at preventing infection in residents without a documented exposure but was just 26 per cent effective in residents with exposure …

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study
1 year, 4 months ago

At least single dose vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality: ICMR study

The Hindu  

At least one dose of vaccine prior to COVID-19 infection provided 60% protection against post-discharge mortality, an Indian Council of Medical Research study on factors related to mortality within one year after discharge in hospitalised COVID-19 patients has found. Overall, the study’s findings suggest that a post-discharge mortality rate of 6.5% in patients hospitalised for COVID-19 warrants a vigilant follow-up. …

Pre-Covid shots provided 60% protection against post-infection deaths: Study
1 year, 4 months ago

Pre-Covid shots provided 60% protection against post-infection deaths: Study

India Today  

The Indian Council of Medical Research, which studied the cause of death in people after recovering from Covid-19 infection, found that those who were vaccinated before contracting the virus had 60 per cent protection against post-discharge mortality. An expert team working at the National Clinical Registry for Covid evaluated factors related to post-discharge mortality during the first year after Covid, …

Post-COVID-19 conditions change a person's immunological response: Study
1 year, 7 months ago

Post-COVID-19 conditions change a person's immunological response: Study

Hindustan Times  

A recent study from Cedars-Sinai's Smidt Heart Institute reveals that extended COVID-19 may be caused by a dysfunction of the immune system. The study, published in BMC Infectious Diseases, found that after people with long COVID-19 received the COVID-19 vaccine, they produced antibodies against the virus that causes COVID-19 for months longer than expected. To study the immune response of …

Pfizer Bivalent Vaccine Reduces Covid-related Death Risk by 68 Pc in Older People: Study
1 year, 8 months ago

Pfizer Bivalent Vaccine Reduces Covid-related Death Risk by 68 Pc in Older People: Study

News 18  

Vulnerable people aged 65 years and over receiving the Pfizer bivalent mRNA vaccine booster dose showed 72 per cent lower risk of Covid-related hospitalisation and 68 per cent lower risk of Covid-related death, according to a new study published in the journal The Lancet Infectious Diseases. Israel has prioritised bivalent mRNA booster vaccines for people at high risk of severe …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Firstpost  

Washington: Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several lingering …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Associated Press  

WASHINGTON — Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

LA Times  

Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisors Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. Pfizer originally studied Paxlovid in the highest-risk COVID-19 patients: unvaccinated adults with other health …

FDA panel narrowly backs Pfizer RSV vaccine for older adults
1 year, 9 months ago

FDA panel narrowly backs Pfizer RSV vaccine for older adults

Associated Press  

WASHINGTON — Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness known as RSV. The Food and Drug Administration panel voted 7-4 on two separate questions of whether Pfizer’s data showed the vaccine was safe and effective against the respiratory virus for …

FDA’s advisors back plan to simplify COVID-19 vaccinations
1 year, 10 months ago

FDA’s advisors back plan to simplify COVID-19 vaccinations

LA Times  

Syringes with COVDI-19 vaccines are prepared at a free public clinic in Lynwood last year. “We’re still protected against severe disease, thank goodness,” even after the latest Omicron strains cropped up, said FDA advisor Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. The first step: The FDA advisory panel voted unanimously that people should get the same …

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims
1 year, 11 months ago

mRNA Covid-19 vaccines can increase serious adverse events? US researcher claims

India TV News  

A US-based researcher has claimed that the messenger RNA Covid-19 vaccine can increase serious adverse events in people, including sudden cardiac deaths. Joseph Fraiman, the lead author of the peer-reviewed research that re-analysed Pfizer & Moderna trials for mRNA Covid-19 vaccine, has tweeted: "I believe the mRNA Covid-19 vaccines need to be withdrawn". In another tweet, he mentioned that the …

First real-world data show Omicron booster kept seniors out of hospitals
1 year, 11 months ago

First real-world data show Omicron booster kept seniors out of hospitals

LA Times  

Vials of Pfizer and BioNTech’s Omicron-targeting COVID-19 vaccine are seen on a production line at a manufacturing facility in Kalamazoo, Mich. In the first real-world test of vaccine boosters specially designed to protect against the Omicron variant, Israeli researchers have found that people 65 and older who got an updated jab were 81% less likely to be hospitalized with COVID-19 …

Covid-19 vaccine protects patients with blood cancer: Study
2 years ago

Covid-19 vaccine protects patients with blood cancer: Study

Hindustan Times  

People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from Covid-19. Covid-19 vaccine protects patients with blood cancer: Study A team led by physicians Dr. Andrea Keppler-Hafkemeyer and Dr. Christine Greil from the Medical Center-University of Freiburgand virologist Prof. Oliver T. Keppler from LMU Munich has now characterized in …

COVID-19: no need for scaremongering, precautions needed, say health experts
2 years ago

COVID-19: no need for scaremongering, precautions needed, say health experts

The Hindu  

Even as the Central and State governments have called for a general alert over a possible rise in COVID-19 cases, public health experts have warned against scaremongering over COVID-19. Public health experts point out that as the new virus variants coming into circulation are the sub variants of Omicron, which in itself was less lethal than Delta, there was no …

NOT REAL NEWS: A look at what didn't happen this week
2 years ago

NOT REAL NEWS: A look at what didn't happen this week

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. The article suggests that these …

Fact-check on vaccine-related misinformation
2 years ago

Fact-check on vaccine-related misinformation

China Daily  

Vaccine is a powerful weapon in the fight against COVID-19. As the second COVID booster becomes available for eligible people and the health authorities work to boost senior vaccination rates, misinformation about COVID-19 vaccines is also rising. The COVID-19 vaccines work by imitating an infection and can cause mild side effects, such as a fever or pain at the injection …

Fact-check on vaccine-related misinformation
2 years ago

Fact-check on vaccine-related misinformation

China Daily  

Vaccine is a powerful weapon in the fight against COVID-19. As the second COVID booster becomes available for eligible people and the health authorities work to boost senior vaccination rates, misinformation about COVID-19 vaccines is also rising. The COVID-19 vaccines work by imitating an infection and can cause mild side effects, such as a fever or pain at the injection …

As COVID-19 spikes in California, booster shots could make all the difference
2 years ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

Vaccinated people now make majority of COVID deaths in US: Report
2 years, 1 month ago

Vaccinated people now make majority of COVID deaths in US: Report

India TV News  

In a startling revelation, a Washington Post analysis has found that more vaccinated people are now dying of the Covid disease and 58 per cent of coronavirus deaths in August in the US "were people who were vaccinated or boosted". The death among vaccinated people is increasing due to the waning efficacy of Covid vaccines and "increasingly contagious strains of …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 1 month ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

US renews push for COVID boosters as data show they protect
2 years, 1 month ago

US renews push for COVID boosters as data show they protect

Associated Press  

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday. Speaking at a White House briefing expected to be his last before he retires from the government at the end of year, Fauci said what “may be the final message I give …

Pfizer, Moderna launch trials to track whether issues arise YEARS after getting their vaccines
2 years, 1 month ago

Pfizer, Moderna launch trials to track whether issues arise YEARS after getting their vaccines

Daily Mail  

Heart inflammation has been the most reported severe side effect of the vaccine Pfizer and Moderna have launched trials to determine whether there are any long-term negative health impacts associated with their Covid vaccines. The same study found that 21 of every million recipients of the original two-dose Pfizer vaccine also suffered the heart issue. A recent Canadian study found …

COVID-19 hospitalizations are rising in infants under 6 months, CDC director says
2 years, 1 month ago

COVID-19 hospitalizations are rising in infants under 6 months, CDC director says

LA Times  

Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said COVID-19 hospitalizations are rising among babies under 6 months old who are too young to be vaccinated. COVID-19 hospitalizations are rising among babies under 6 months old, and the Centers for Disease Control and Prevention is urging mothers to get vaccinated to reduce the risk of infection …

Pfizer study says updated COVID boosters rev up antibody protection
2 years, 1 month ago

Pfizer study says updated COVID boosters rev up antibody protection

LA Times  

Booster shots of the Pfizer COVID-19 vaccine sit ready to be used at a vaccine clinic in Townshend, Vt. Pfizer’s updated COVID-19 booster significantly revved up adults’ virus-fighting antibodies, the company said Friday, releasing early findings from a rigorous study of the new shots. Pfizer said people 55 and older who got the Omicron-targeting booster had four-fold higher antibody levels …

New bivalent Covid vaccines DON'T give people better immunity, studies show
2 years, 1 month ago

New bivalent Covid vaccines DON'T give people better immunity, studies show

Daily Mail  

The new bivalent Covid vaccines are no more effective than the original shots, according to two new studies. In both studies, people who had already been triple vaccinated were given either a standard Covid shot or an updated bivalent booster. President Joe Biden got his updated booster yesterday — his fifth shot to date — in the latest White House …

Covid-19 vaccine study links side effects with greater antibody response
2 years, 2 months ago

Covid-19 vaccine study links side effects with greater antibody response

CNN  

CNN — People who reported experiencing side effects to the Pfizer/BioNTech and Moderna Covid-19 vaccines such as fever, chills or muscle pain tended to have a greater antibody response following vaccination, according to new research. “In conclusion, these findings support reframing postvaccination symptoms as signals of vaccine effectiveness and reinforce guidelines for vaccine boosters in older adults,” the researchers – …

Booster Dose Of Covid-19 Vaccine Highly Effective In Patients With Cirrhosis: Study
2 years, 2 months ago

Booster Dose Of Covid-19 Vaccine Highly Effective In Patients With Cirrhosis: Study

ABP News  

New York, Oct 20 Among cirrhosis patients, receiving a third dose of the vaccine was associated with an 80 per cent reduction in overall Covid-19 and a 100 per cent reduction in the severe course of the infection or death, says a new report. For the study, the team performed a retrospective cohort study of patients with cirrhosis who received …

Repeat covid vaccinations opened to all as postive tests mount
2 years, 2 months ago

Repeat covid vaccinations opened to all as postive tests mount

Dutch News  

Everyone over the age of 12 is now being invited to sign up for another coronavirus vaccination, the health ministry has confirmed. With covid infections once again on the rise, health officials say getting the top-up jabs will help slow the spread of the virus. People aged 40 to 60 can make an appointment via website planjeprik.nl next week, while …

Repeat covid vaccinations opened to all as postive tests mount
2 years, 2 months ago

Repeat covid vaccinations opened to all as postive tests mount

Dutch News  

Everyone over the age of 12 is now being invited to sign up for another coronavirus vaccination, the health ministry has confirmed. With covid infections once again on the rise, health officials say getting the top-up jabs will help slow the spread of the virus. People aged 40 to 60 can make an appointment via website planjeprik.nl next week, while …

Pfizer says bivalent booster increases antibodies for Omicron variants
2 years, 2 months ago

Pfizer says bivalent booster increases antibodies for Omicron variants

LA Times  

Pfizer Inc. and its German vaccine partner BioNTech said their new COVID-19 booster designed to target the dominant Omicron subvariant produced more antibodies against the intended strains than did the original version of the shot. Pfizer and BioNTech plan to release additional data on the COVID-19 shots in the coming weeks to measure immune responses one month after administration of …

Covid-19: Pfizer faces backlash for creating pro-vaccine Marvel comic
2 years, 2 months ago

Covid-19: Pfizer faces backlash for creating pro-vaccine Marvel comic

Daily Mail  

Pfizer's Covid vaccine comic was today slammed as 'ethically dubious in the extreme' for trying to appeal to children. It features a grandfather and his family who get a Covid vaccine, the Avengers who represent the Covid vaccines and Ironman who represents the new Covid vaccine, and Ultron who represents Covid's evolution The grandpa is shown waiting at a clinic …

It’s flu vaccine time and seniors need revved-up shots
2 years, 2 months ago

It’s flu vaccine time and seniors need revved-up shots

Associated Press  

Doctors have a message for vaccine-weary Americans: Don’t skip your flu shot this fall -- and seniors, ask for a special extra-strength kind. This year we know flu is back,” said influenza specialist Richard Webby of St. Jude Children’s Research Hospital in Memphis. Here’s what to know: REVVED-UP SHOTS FOR SENIORS As people get older, their immune system doesn’t respond …

Discover Related